All updated as on -
By 2023, the cardiac valve industry had grown to a value of $7.22 billion. With a predicted CAGR (compound annual growth rate) of 7.50% from 2024 to 2031, the cardiac valve market is expected to expand from $7.17B in 2024 to $12.27B in 2031. Key market drivers augmenting the market growth include the increasing burden of valvular heart disease and individuals leading increasingly sedentary lifestyles.
One of the heart's most important components, the cardiac valve ensures that blood flows optimally between the chambers of the heart. The unique aperture allows for accurate blood flow regulation through its rigorous regulatory mechanism. If the heart's native valve becomes damaged or impaired, a treatment to replace it is needed so the heart can work normally again. An intricately designed unidirectional valve, the implanted device efficiently controls the direction and optimal pressure of blood circulation.
An essential role of the cardiovascular system is to ensure that blood is effectively and continuously transported around the heart. This allows for adequate circulation to different parts of the body that need oxygen and nutrients. The heart valve plays a crucial role in maintaining the circulatory system's health and functionality by carefully protecting the flow of blood.
Factors that are expected to contribute to the growth of the cardiac valve market from 2023 to 2029 include an aging population, an increase in the number of patients with cardiovascular diseases, the increasing usage of these devices to regulate blood pressure, and a surge in investments for the creation of cutting-edge products. Conversely, the cardiac valve market is expected to experience growth throughout the forecast period due to the multiple opportunities made possible by people's changing lifestyles.
Cardiovascular disease and heart valve disease have recently become more common, which has contributed to the market's expansion. Heart valve devices have recently benefited from technological advancements, which is driving the market forward over the forecast period. Another factor propelling the market is congenital heart disease. The ever-evolving lifestyles of people are also contributing to the market demand, as they are increasingly relying on food from outside sources and neglecting their health, resulting in an increase in the frequency of cardiac diseases. Mergers and acquisitions would strengthen the market during the projection period.
Rising infection rates linked to cardiac implant usage and the high cost of cardiac valves are expected to hinder the cardiac valve market over the projected period. Strict product regulations imposed by the government are making it difficult for the market to advance. Government rules concerning the usage and sale of medical products are having an impact on the market. Patients' health is at risk due to a lack of qualified surgical professionals, but the market is having trouble finding a solution, therefore they will lose money during the forecast period. Expansion of the market is being constrained by the high cost of the equipment and the surgical process. Concerns over reimbursement are another factor preventing the market from reaching its full potential.
Recent developments, trade regulations, import-export analysis, production optimization, value chain management, market share, influence of local and domestic market players, opportunities for strategic market growth, market size, category market growth, application niches and dominance, product approvals, product launches, geographic expansions, and technological innovations are all detailed in this cardiac valve market report.
Factors propelling the market's growth include an aging population, a change in people's active-to-sedentary lifestyles, new innovations in heart valves, heightened awareness of surgical treatment alternatives, and an increase in the desire for less invasive surgeries. For example, according to the American College of Cardiology, around 5 million Americans are affected by heart valve disease annually. The high price of cardiac valves and the presence of alternative treatments for heart valve disease are two major factors limiting the market's expansion. The capacity of computational tools to simulate various fluid mechanics aspects such as pressure drops, regurgitation volumes, or turbulence is another powerful element impacting the heart valve repair and replacement industry. Furthermore, computational methods allow for accurate valvar disease detection, which leads to effective treatment and grows the market for cardiac valve replacement and repair.
Report Coverage
Global Cardiac Valve research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Cardiac Valve report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Cardiac Valve competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Cardiac Valve market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Cardiac Valve market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Cardiac Valve market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Medtronic, Edwards Lifesciences Corporation, Boston Scientific Corporation, LivaNova PLC, Abbott, CryoLife, Inc, On-X Life Technologies, Inc., Colibri Heart Valve, JenaValve Technology, Inc., and TTK HealthCare
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Cardiac Valve market based on the below-mentioned segments:
Global Cardiac Valve Market, By Type
Mechanical Valves
Tissue/Bioprosthetic Valves
Transcatheter Heart Valves/Percutaneous Heart Valves
Others
Global Cardiac Valve market, By Treatment
Cardiac Wall Repair
Cardiac Wall Replacement
Others
Global Cardiac Valve Market, By End User
Hospital & Clinics
Specialty Centers
Cardiac Research Institute
Others
Global Cardiac Valve market, Regional Analysis
One of the heart's most important components, the cardiac valve ensures that blood flows optimally between the chambers of the heart. The unique aperture allows for accurate blood flow regulation through its rigorous regulatory mechanism. If the heart's native valve becomes damaged or impaired, a treatment to replace it is needed so the heart can work normally again. An intricately designed unidirectional valve, the implanted device efficiently controls the direction and optimal pressure of blood circulation.
An essential role of the cardiovascular system is to ensure that blood is effectively and continuously transported around the heart. This allows for adequate circulation to different parts of the body that need oxygen and nutrients. The heart valve plays a crucial role in maintaining the circulatory system's health and functionality by carefully protecting the flow of blood.
Factors that are expected to contribute to the growth of the cardiac valve market from 2023 to 2029 include an aging population, an increase in the number of patients with cardiovascular diseases, the increasing usage of these devices to regulate blood pressure, and a surge in investments for the creation of cutting-edge products. Conversely, the cardiac valve market is expected to experience growth throughout the forecast period due to the multiple opportunities made possible by people's changing lifestyles.
Cardiovascular disease and heart valve disease have recently become more common, which has contributed to the market's expansion. Heart valve devices have recently benefited from technological advancements, which is driving the market forward over the forecast period. Another factor propelling the market is congenital heart disease. The ever-evolving lifestyles of people are also contributing to the market demand, as they are increasingly relying on food from outside sources and neglecting their health, resulting in an increase in the frequency of cardiac diseases. Mergers and acquisitions would strengthen the market during the projection period.
Rising infection rates linked to cardiac implant usage and the high cost of cardiac valves are expected to hinder the cardiac valve market over the projected period. Strict product regulations imposed by the government are making it difficult for the market to advance. Government rules concerning the usage and sale of medical products are having an impact on the market. Patients' health is at risk due to a lack of qualified surgical professionals, but the market is having trouble finding a solution, therefore they will lose money during the forecast period. Expansion of the market is being constrained by the high cost of the equipment and the surgical process. Concerns over reimbursement are another factor preventing the market from reaching its full potential.
Recent developments, trade regulations, import-export analysis, production optimization, value chain management, market share, influence of local and domestic market players, opportunities for strategic market growth, market size, category market growth, application niches and dominance, product approvals, product launches, geographic expansions, and technological innovations are all detailed in this cardiac valve market report.
Factors propelling the market's growth include an aging population, a change in people's active-to-sedentary lifestyles, new innovations in heart valves, heightened awareness of surgical treatment alternatives, and an increase in the desire for less invasive surgeries. For example, according to the American College of Cardiology, around 5 million Americans are affected by heart valve disease annually. The high price of cardiac valves and the presence of alternative treatments for heart valve disease are two major factors limiting the market's expansion. The capacity of computational tools to simulate various fluid mechanics aspects such as pressure drops, regurgitation volumes, or turbulence is another powerful element impacting the heart valve repair and replacement industry. Furthermore, computational methods allow for accurate valvar disease detection, which leads to effective treatment and grows the market for cardiac valve replacement and repair.
Report Coverage
Global Cardiac Valve research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Cardiac Valve report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Cardiac Valve competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Cardiac Valve market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2031 |
| Base Year | 2023 |
| Forecast Period | 2023-2031 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Medtronic, Edwards Lifesciences Corporation, Boston Scientific Corporation, LivaNova PLC, Abbott, CryoLife, Inc, On-X Life Technologies, Inc., Colibri Heart Valve, JenaValve Technology, Inc., and TTK HealthCare |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Cardiac Valve Market from 2021 to 2031.
- Market Forecast for Cardiac Valve Market from 2021 to 2031.
- Regional Market Share and Revenue from 2021 to 2031.
- Country Market share within region from 2021 to 2031.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Cardiac Valve competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Cardiac Valve
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Cardiac Valve market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Cardiac Valve market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Medtronic, Edwards Lifesciences Corporation, Boston Scientific Corporation, LivaNova PLC, Abbott, CryoLife, Inc, On-X Life Technologies, Inc., Colibri Heart Valve, JenaValve Technology, Inc., and TTK HealthCare
Primary Target Market
- Market Players of Cardiac Valve
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Cardiac Valve market based on the below-mentioned segments:
Global Cardiac Valve Market, By Type
Mechanical Valves
Tissue/Bioprosthetic Valves
Transcatheter Heart Valves/Percutaneous Heart Valves
Others
Global Cardiac Valve market, By Treatment
Cardiac Wall Repair
Cardiac Wall Replacement
Others
Global Cardiac Valve Market, By End User
Hospital & Clinics
Specialty Centers
Cardiac Research Institute
Others
Global Cardiac Valve market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive cardiac valve market market research and competitor analysis for your business to help you develop more profound insights into the cardiac valve market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the cardiac valve market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.